Comparing a multicomponent intervention versus a single component intervention for people with co-occurring substance use and mental health disorders: study protocol of a hybrid type I trial

Authors

  • Paige M. Shaffer Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA https://orcid.org/0000-0002-6520-1044
  • Abigail F. Helm Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA https://orcid.org/0000-0001-6966-0179
  • Marinna L. Kaufman Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA https://orcid.org/0009-0001-5663-5457
  • Wenjun Li Department of Public Health, Center for Health Statistics and Biostatistics Core, University of Massachusetts, Lowell, MA, USA https://orcid.org/0000-0001-5335-7386
  • Krishna C. Poudel Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, MA, USA
  • David A. Smelson Institute for Global Health, University of Massachusetts Amherst, MA, USA

DOI:

https://doi.org/10.18203/2349-3259.ijct20253334

Keywords:

Addiction, Mental health, Substance use, Multicomponent interventions, Public health

Abstract

Background: Substance use and mental health are growing public health problems in the United States. People with co-occurring mental health and substance use disorders (COD) often have complex social determinants of health (SDOH) needs and struggle to engage in treatment. Linkage and multicomponent wraparound interventions, including maintaining independence and sobriety through systems integration, outreach and networking (MISSION), have gained popularity as solutions to increase treatment engagement and address behavioral health and SDOH needs of clients with COD. This protocol offers an overview of an effectiveness trial and a process evaluation of MISSION being delivered in a city public health setting.

Methods: This study will use a hybrid type I effectiveness and implementation design with a randomized controlled trial. People with COD will be randomized to one of two treatments: a multicomponent COD intervention (MISSION), or a peer delivered linkage-only intervention (PLS). Secondary aims include the examination of mechanisms of action and a sequential mixed methods process evaluation to inform the sustainability and future implementation of MISSION.

Conclusions: This trial will help determine the effectiveness of MISSION compared to PLS to improve engagement, and reduce substance use and mental health symptoms. This trial is the first to implement MISSION within a public health department setting which has important implications for policymakers and treatment providers within behavioral health fields.

Trial Registration: Trial registration number is NCT05713695, registered on 27 January 2023.

Metrics

Metrics Loading ...

References

Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Available at: https://www.samhsa.gov/ data/sites/default/files/reports/rpt29393/2019NSDUHFFRPDFWHTML/2019NSDUHFFR090120.htm. Accessed on 28 September 2024.

US Department of Health and Human Services Washington (DC). Substance Abuse and Mental Health Services Administration (US); Office of the Surgeon General (US). Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. 2016.

CDC, National Center for Health Statistics Atlanta, GA. Wide-ranging online data for epidemiologic research (WONDER). 2020. Available at: http://wonder.cdc.gov. Accessed on 28 September 2024.

CDC. Percent of drug overdose deaths by quarter, by sex, age, and race and Hispanic origin: United States 2019-Q1 through 2020-Q4. NCHS, National Vital statistics System. Available at: https://www.cdc.gov /nchs/data/health_policy/Provisional-Drug-Overdose-Deaths-by-Quarter-and-Demographic-Characteristics-2019-to-2020.pdf. Accessed on 28 September 2024.

Flynn PM, Brown BS. Co-occurring disorders in substance abuse treatment: issues and prospects. J Subst Abuse Treat. 2008;34(1):36-47. DOI: https://doi.org/10.1016/j.jsat.2006.11.013

Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-27. DOI: https://doi.org/10.1001/archpsyc.62.6.617

Wu LT, Zhu H, Ghitza UE. Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data. Drug Alcohol Depend. 2018;192:316-23. DOI: https://doi.org/10.1016/j.drugalcdep.2018.08.013

Rosenberg SD, Drake RE, Brunette MF, Wolford GL, Marsh BJ. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders. Aids. 2005;19:S26-33. DOI: https://doi.org/10.1097/01.aids.0000192067.94033.aa

Baillargeon J, Penn JV, Knight K, Harzke AJ, Baillargeon G, Becker EA. Risk of reincarceration among prisoners with co-occurring severe mental illness and substance use disorders. Adm Policy Ment Health. 2010;37(4):367-74. DOI: https://doi.org/10.1007/s10488-009-0252-9

Jones CM, McCance-Katz EF. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug Alcohol Depend. 2019;197:78-82. DOI: https://doi.org/10.1016/j.drugalcdep.2018.12.030

Cicero TJ, Ellis MS, Kasper ZA. Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis. Am J Public Health. 2020;110(2):244-50. DOI: https://doi.org/10.2105/AJPH.2019.305412

Mahoney JJ, 3rd, Winstanley EL, Lander LR, Berry JH, Marshalek PJ, Haut MW, et al. High prevalence of co-occurring substance use in individuals with opioid use disorder. Addict Behav. 2021;114:106752. DOI: https://doi.org/10.1016/j.addbeh.2020.106752

Farré M, Mas A, Torrens M, Moreno V, Camí J. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug Alcohol Depend. 2002;65(3):283-90. DOI: https://doi.org/10.1016/S0376-8716(01)00171-5

Naeger S, Mutter R, Ali MM, Mark T, Hughey L. Post-discharge treatment engagement among patients with an opioid-use disorder. J Subst Abuse Treat. 2016;69:64-71. DOI: https://doi.org/10.1016/j.jsat.2016.07.004

Proctor SL, Copeland AL, Kopak AM, Hoffmann NG, Herschman PL, Polukhina N. Predictors of patient retention in methadone maintenance treatment. Psychol Addict Behav. 2015;29(4):906-17. DOI: https://doi.org/10.1037/adb0000090

Richter LM, Vuolo L, Salmassi MS. Stigma and addiction treatment. In: Avery J, Avery J, editors. The Stigma of Addiction. Springer, Cham. 2019;93-130. DOI: https://doi.org/10.1007/978-3-030-02580-9_7

Natale-Pereira A, Enard KR, Nevarez L, Jones LA. The role of patient navigators in eliminating health disparities. Cancer. 2011;117:3543-52. DOI: https://doi.org/10.1002/cncr.26264

de Heer HD, Balcazar HG, Wise S, Redelfs AH, Rosenthal EL, Duarte MO. Improved cardiovascular risk among hispanic border participants of the Mi Corazón Mi Comunidad Promotores De Salud Model: The HEART II cohort intervention study 2009-2013. Front Public Health. 2015;3:149. DOI: https://doi.org/10.3389/fpubh.2015.00149

McBrien KA, Ivers N, Barnieh L, Lorenzetti DL, Nicholas D, Tonelli M, et al. Patient navigators for people with chronic disease: A systematic review. PLoS One. 2018;13(2):e0191980. DOI: https://doi.org/10.1371/journal.pone.0191980

Paskett ED, Harrop JP, Wells KJ. Patient navigation: an update on the state of the science. CA Cancer J Clin. 2011;61(4):237-49. DOI: https://doi.org/10.3322/caac.20111

Shlay JC, Barber B, Mickiewicz T, Maravi M, Drisko J, Estacio R, et al. Reducing cardiovascular disease risk using patient navigators, Denver, Colorado, 2007-2009. Prev Chronic Dis. 2011;8(6):A143.

Griswold KS, Homish GG, Pastore PA, Leonard KE. A randomized trial: are care navigators effective in connecting patients to primary care after psychiatric crisis? Community Ment Health J. 2010;46(4):398-402. DOI: https://doi.org/10.1007/s10597-010-9300-x

Hunt GM, Azrin NH. A community-reinforcement approach to alcoholism. Behav Res Ther. 1973;11(1):91-104. DOI: https://doi.org/10.1016/0005-7967(73)90072-7

Meyers RJ, Smith JE. Clinical guide to alcohol treatment: The Community Reinforcement Approach. Guilford Press. 1995.

Meyers RJ, Roozen HG, Smith JE. The community reinforcement approach: an update of the evidence. Alcohol Res Health. 2011;33(4):380-8.

Miller WR, Meyers RJ, Tonigan JS. Engaging the unmotivated in treatment for alcohol problems: A comparison of three strategies for intervention through family members. J Consult Clin Psychol. 1999;67(5):688-97. DOI: https://doi.org/10.1037//0022-006X.67.5.688

Meyers RJ, Miller WR. A community reinforcement approach to addiction treatment. Cambridge University Press. 2001. DOI: https://doi.org/10.1017/CBO9780511570117

First M, Williams J, Karg R, Spitzer R. Structured clinical interview for DSM-5—Research version (SCID-5 for DSM-5, research version; SCID-5-RV. Arlington, VA: American Psychiatric Association. 2015. Available at: https://apsychoserver.psychofizz. psych.arizona.edu/JJBAReprints/PSYC621/694A/SCID/SCID-5-CV.pdf. Accessed on 28 September 2024.

Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42(5):533-44. DOI: https://doi.org/10.1007/s10488-013-0528-y

Herman DB, Mandiberg JM. Critical time intervention: model description and implications for the significance of timing in social work interventions. Res Soc Work Pract. 2010;20(5):502-8. DOI: https://doi.org/10.1177/1049731509360667

Susser E, Valencia E, Conover S, Felix A, Tsai WY, Wyatt RJ. Preventing recurrent homelessness among mentally ill men: a "critical time" intervention after discharge from a shelter. Am J Public Health. 1997;87(2):256-62. DOI: https://doi.org/10.2105/AJPH.87.2.256

Ziedonis DM, Stern R. Dual recovery therapy for schizophrenia and substance abuse. Psychiatric Annals. 2001;31(4):255-64. DOI: https://doi.org/10.3928/0048-5713-20010401-09

Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Integrated Treatment for Co-Occurring Disorders: The Evidence. (DHHS Pub. No. SMA-08-4366). Available at: https://library.sam hsa.gov/sites/default/files/ebp-kit-the-evidence-10242019.pdf. Accessed on 28 September 2024.

Klein AR, Cnaan RA, Whitecraft J. Significance of peer social support with dually diagnosed clients: findings from a pilot study. Res Soc Work Pract. 1998;8(5):529-51. DOI: https://doi.org/10.1177/104973159800800503

What are Peer Recovery Support Services? HHS Publication No. (SMA) 09-4454. Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services. Available at: https://library.samhsa.gov/product/ what-are-peer-recovery-support-services/sma09-4454. Accessed on 28 September 2024.

Chinman M, George P, Dougherty RH. Peer support services for individuals with serious mental illnesses: assessing the evidence. Psychiatr Serv. 2014;65(4):429-41. DOI: https://doi.org/10.1176/appi.ps.201300244

White WL. Nonclinical addiction recovery support services: History, rationale, models, potentials, and pitfalls. Alcoholism Treat Q. 2010;28(3):256-72. DOI: https://doi.org/10.1080/07347324.2010.488527

Faces and Voices of Recovery. Addiction Recovery Peer Services Roles: Recovery Management in Health Reform. Available at: https://facesandvoices ofrecovery.org/wp-content/uploads/2019/06/Addict ion-Recovery-Peer-Service-Roles-Recovery-Management-in-Health-Reform.pdf. Accessed on 28 September 2024.

Kirk MA, Kelley C, Yankey N, Birken SA, Abadie B, Damschroder L. A systematic review of the use of the Consolidated Framework for Implementation Research. Implement Sci. 2016;11(1):72. DOI: https://doi.org/10.1186/s13012-016-0437-z

Zhao X, Lynch Jr JG, Chen Q. Reconsidering Baron and Kenny: myths and truths about mediation analysis. J Consum Res. 2010;37(2):197-206. DOI: https://doi.org/10.1086/651257

Downloads

Published

2025-10-23

How to Cite

Shaffer, P. M., Helm, A. F., Kaufman, M. L., Li, W., Poudel, K. C., & Smelson, D. A. (2025). Comparing a multicomponent intervention versus a single component intervention for people with co-occurring substance use and mental health disorders: study protocol of a hybrid type I trial. International Journal of Clinical Trials, 12(4), 287–296. https://doi.org/10.18203/2349-3259.ijct20253334